421 related articles for article (PubMed ID: 31107146)
21. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
Aris P; Boroumand MA; Rahbar M; Douraghi M
Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
[TBL] [Abstract][Full Text] [Related]
22. Combined relay therapy with oral cefixime and clavulanate for febrile urinary tract infection caused by extended-spectrum β-lactamase-producing Escherichia coli.
Madhi F; Biscardi S; Bingen E; Jaby O; Epaud R; Cohen R
Pediatr Infect Dis J; 2013 Jan; 32(1):96-7. PubMed ID: 23241996
[No Abstract] [Full Text] [Related]
23. [Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].
de Cueto M; Hernández JR; López-Cerero L; Morillo C; Pascual A
Enferm Infecc Microbiol Clin; 2006 Dec; 24(10):613-6. PubMed ID: 17194386
[TBL] [Abstract][Full Text] [Related]
24. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
[TBL] [Abstract][Full Text] [Related]
25. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Lampri N; Galani I; Poulakou G; Katsarolis I; Petrikkos G; Giamarellou H; Souli M
J Antimicrob Chemother; 2012 Oct; 67(10):2424-8. PubMed ID: 22665388
[TBL] [Abstract][Full Text] [Related]
26. Plasmid-mediated AmpC beta-lactamase-producing Escherichia coli causing urinary tract infection in the Auckland community likely to be resistant to commonly prescribed antimicrobials.
Drinkovic D; Morris AJ; Dyet K; Bakker S; Heffernan H
N Z Med J; 2015 Mar; 128(1410):50-9. PubMed ID: 25829039
[TBL] [Abstract][Full Text] [Related]
27. Microbiology and Drug Resistance of Pathogens in Patients Hospitalized at the Nephrology Department in the South of Poland.
Michno M; Sydor A; Wałaszek M; Sułowicz W
Pol J Microbiol; 2018; 67(4):517-524. PubMed ID: 30550238
[TBL] [Abstract][Full Text] [Related]
28. Urinary tract infection caused by extended-spectrum β-lactamase-producing bacteria: Risk factors and antibiotic resistance.
Albaramki JH; Abdelghani T; Dalaeen A; Khdair Ahmad F; Alassaf A; Odeh R; Akl K
Pediatr Int; 2019 Nov; 61(11):1127-1132. PubMed ID: 31206219
[TBL] [Abstract][Full Text] [Related]
29. A combination of mecillinam and amoxicillin/clavulanate can restore susceptibility of high-level TEM-1-producing Escherichia coli to mecillinam.
Birgy A; Delecourt M; Geslain G; Desselas E; Caseris M; Magnan M; Mariani-Kurkdjian P; Bidet P; Bonacorsi S
J Antimicrob Chemother; 2017 Jul; 72(7):1911-1914. PubMed ID: 28369441
[TBL] [Abstract][Full Text] [Related]
30. [Strain of Escherichia coli resistant to broad-spectrum cephalosporin and amoxicillin/clavulanic acid].
Martín-Pozo A; Alós JI
Rev Esp Quimioter; 2012 Sep; 25(3):222-3. PubMed ID: 22987271
[No Abstract] [Full Text] [Related]
31.
Gupta A; Malik S; Kaminski M; Landman D; Quale JM
Microb Drug Resist; 2022 Apr; 28(4):419-424. PubMed ID: 35451880
[TBL] [Abstract][Full Text] [Related]
32. Alternatives to carbapenems in ESBL-producing Escherichia coli infections.
Fournier D; Chirouze C; Leroy J; Cholley P; Talon D; Plésiat P; Bertrand X
Med Mal Infect; 2013 Feb; 43(2):62-6. PubMed ID: 23433608
[TBL] [Abstract][Full Text] [Related]
33. Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
Birgy A; Madhi F; Jung C; Levy C; Cointe A; Bidet P; Hobson CA; Bechet S; Sobral E; Vuthien H; Ferroni A; Aberrane S; Cuzon G; Beraud L; Gajdos V; Launay E; Pinquier D; Haas H; Desmarest M; Dommergues MA; Cohen R; Bonacorsi S;
J Antimicrob Chemother; 2021 Oct; 76(11):2839-2846. PubMed ID: 34453533
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the effectiveness of three different cephalosporin/clavulanate combinations for the phenotypic confirmation of extended-spectrum beta-lactamase producing bacteria isolated from urine samples at National Public Health Laboratory, Kathmandu, Nepal.
Bhandari R; Pant ND; Poudel A; Sharma M
BMC Res Notes; 2016 Aug; 9():390. PubMed ID: 27488224
[TBL] [Abstract][Full Text] [Related]
35. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
Tsui K; Wong SS; Lin LC; Tsai CR; Chen LC; Huang CH
J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
[TBL] [Abstract][Full Text] [Related]
36. The detection of ESBL-producing Escherichia coli in patients with symptomatic urinary tract infections using different diffusion methods in a rural setting.
Harwalkar A; Sataraddi J; Gupta S; Yoganand R; Rao A; Srinivasa H
J Infect Public Health; 2013 Apr; 6(2):108-14. PubMed ID: 23537823
[TBL] [Abstract][Full Text] [Related]
37. Relay oral therapy in febrile urinary tract infections caused by extended spectrum beta-lactamase-producing Enterobacteriaceae in children: A French multicenter study.
Lignieres G; Birgy A; Jung C; Bonacorsi S; Levy C; Angoulvant F; Grimprel E; Dommergues MA; Gillet Y; Craiu I; Rybak A; De Pontual L; Dubos F; Cixous E; Gajdos V; Pinquier D; Andriantahina I; Soussan-Banini V; Georget E; Launay E; Vignaud O; Cohen R; Madhi F
PLoS One; 2021; 16(9):e0257217. PubMed ID: 34529722
[TBL] [Abstract][Full Text] [Related]
38. Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients.
Fatima S; Muhammad IN; Usman S; Jamil S; Khan MN; Khan SI
Indian J Pharmacol; 2018; 50(2):69-74. PubMed ID: 30100654
[TBL] [Abstract][Full Text] [Related]
39. Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.
Kresken M; Pfeifer Y; Hafner D; Wresch R; Körber-Irrgang B;
Int J Antimicrob Agents; 2014 Oct; 44(4):295-300. PubMed ID: 25223936
[TBL] [Abstract][Full Text] [Related]
40. [Fosfomycin susceptibility of urinary Escherichia coli isolates producing extended-spectrum beta-lactamase according to CLSI and EUCAST recommendations].
Cağan Aktaş S; Gençer S; Batırel A; Hacıseyitoğlu D; Ozer S
Mikrobiyol Bul; 2014 Oct; 48(4):545-55. PubMed ID: 25492650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
